Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monya Baker

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
Nature|December 2, 2016
Stat-checking software stirs up psychologyMonya Baker
Nature Biotechnology|October 9, 2007
Industry concerns mount over CIRM grantsMonya Baker
Nature|September 16, 2016
Reproducibility: Respect your cells!Monya Baker
Nature|October 4, 2008
Cell therapy: being patientMonya Baker
Nature Biotechnology|March 15, 2005
In biomarkers we trust?Monya Baker
Nature|August 8, 2007
Fountain of funding for youthMonya Baker
Nature Biotechnology|November 10, 2006
From bench to briefsMonya Baker
Nature|December 5, 2008
Melanoma in mice casts doubt on scarcity of cancer stem cellsMonya Baker
Nature Biotechnology|July 10, 2009
iZumi's plans to capitalize on iPS cellsMonya Baker
Nature Biotechnology|September 12, 2007
Funding crunch forces stem cell company to abandon therapiesMonya Baker
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
Nature|December 2, 2016
Stat-checking software stirs up psychologyMonya Baker
Nature Biotechnology|October 9, 2007
Industry concerns mount over CIRM grantsMonya Baker
Nature|September 16, 2016
Reproducibility: Respect your cells!Monya Baker
Nature|October 4, 2008
Cell therapy: being patientMonya Baker
Nature Biotechnology|March 15, 2005
In biomarkers we trust?Monya Baker
Nature|August 8, 2007
Fountain of funding for youthMonya Baker
Nature Biotechnology|November 10, 2006
From bench to briefsMonya Baker
Nature|December 5, 2008
Melanoma in mice casts doubt on scarcity of cancer stem cellsMonya Baker
Nature Biotechnology|July 10, 2009
iZumi's plans to capitalize on iPS cellsMonya Baker
Nature Biotechnology|September 12, 2007
Funding crunch forces stem cell company to abandon therapiesMonya Baker
Pageof 16